Newel Health Appoints Ervin Ukaj as New CEO

This appointment marks a turning point for Newel Health in advancing Digital Therapeutics and Healthcare Innovation Salerno, Italy | Newel Health, …

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)

NJ-based digital health company Curio Digital Therapeutics Inc. announces 510(k) clearance for MamaLift PlusTM, an eight-week prescription digital therapeutic (PDT) for symptomatic treatment for postpartum depression (PPD). Use of MamaLift Plus should...

Exploring the Digital Health Landscape in the WHO European Region

A new report by the World Health Organization (WHO) provides insights into the digital health landscape in the WHO European Region. The report, titled…

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology platform which revolutionizes h...

March 2024: selected Women’s Health updates

It’s time for my curated women’s health updates, and there’s plenty to share this March. Let’s go! Menopause and neuroscience. 70% of women exp…

New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program

The study marks Omada Health’s 28th peer-reviewed publication, demonstrating the company's commitment to evaluating the effectiveness of its virtual care programsSAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual-first healthcare provider, rece...

Digital Therapeutics: transforming healthcare from bench to bedside

In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) emerge as a transformative force, offering innovative solutions to improve…

Revolutionizing Clinical Diagnostics with Smartwatch Innovation

Recently, the Food and Drug Administration (FDA) issued a press release warning against the use of wearable devices in measuring blood glucose levels.…

Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan

Japanese Product Now Under Review for Nationwide Marketing ApprovalBOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili’s digital ...

Biofourmis announces major agreements with top pharmaceutical companies

Biofourmis, a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms.  The n…